Výsledky vyhledávání - "Naotaka Sunada"

Autor: Haruhiko Ogata, Yosuke Koshikawa, Shinpei Nonen, Yoshiteru Takekita, Naotaka Sunada, Masataka Wakeno, Toshihiko Kinoshita, Masaki Kato

Publikováno v: Neuropsychobiology. 78:136-144

Background: Glycogen synthase kinase-3β (GSK-3β) polymorphisms are known to influence hippocampal brain tissue volume in individuals with major depressive disorder (MDD). However, the effects of the GSK-3β gene single nucleotide polymorphisms (SNP

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2447aa867b1909a44ca3ed4c75d86ab3
https://doi.org/10.1159/000500614

Zobrazit plný text záznamu

Sevoflurane in electroconvulsive therapy: A systematic review and meta-analysis of randomised trials

Autor: Taro Suwa, Nobuatsu Aoki, Hirotsugu Kawashima, Toshiya Murai, Yoshiteru Takekita, Aran Tajika, Toshiyuki Shimizu, Naotaka Sunada, Toshihiko Kinoshita

Publikováno v: Journal of psychiatric research. 141

Sevoflurane is the most commonly used inhaled anaesthetic in electroconvulsive therapy (ECT). The objective of this study was to provide an up-to-date and comprehensive review on how the use of sevoflurane affects seizure adequacy (seizure duration a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7be2e9c99aeea61d14213ef2fc942dbb
https://pubmed.ncbi.nlm.nih.gov/34352164

Zobrazit plný text záznamu

Divergence of dose-response with asenapine: a cluster analysis of randomized, double-blind, and placebo control study

Autor: Minami Naito, Shuichi Hiraoka, Yoshiteru Takekita, Atsuko Yamamoto, Nobuatsu Aoki, Toshihiko Kinoshita, Yasuhiro Iwama, Tomoyo Yanagida, Chikashi Takano, Yosuke Koshikawa, Haruhiko Ogata, Masaki Kato, Toshiya Funatsuki, Naotaka Sunada

Publikováno v: CNS spectrums. 27(3)

BackgroundDifferences in psychiatric background and dose–response to asenapine in patients with schizophrenia were examined based on efficacy and safety, using data obtained in a double-blind, placebo-controlled trial.MethodsPatients with schizophr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33c0cbb9f9c97309affca9a86a0671ae
https://pubmed.ncbi.nlm.nih.gov/33461636

Zobrazit plný text záznamu

Non response at week 4 as clinically useful indicator for antidepressant combination in major depressive disorder. A sequential RCT

Autor: Toshihiko Kinoshita, Yosuke Koshikawa, Alessandro Serretti, Yoshiteru Takekita, Ai Onohara, Keiichiro Nishida, Yoshiyuki Hatashita, Hiroki Bandou, Naotaka Sunada, Masaki Kato, Shiho Sakai

Publikováno v: Journal of Psychiatric Research. 89:97-104

We aimed to compare the efficacy and tolerability of mirtazapine versus SSRIs and to assess whether “non-response at week 4” may be a clinical indicator for combining mirtazapine and SSRIs for subsequent treatment. One-hundred fifty-four outpatie

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0fc5873d571522bd6f4f3fdd57411cf7
https://doi.org/10.1016/j.jpsychires.2017.02.003

Zobrazit plný text záznamu

The Comparative Effects of Risperidone Long-Acting Injection and Paliperidone Palmitate on Social Functioning in Schizophrenia: A 6-Month, Open-Label, Randomized Controlled Pilot Trial

Autor: Keiichiro Nishida, Masaki Kato, Yosuke Koshikawa, Chiara Fabbri, Naotaka Sunada, Yoshiteru Takekita, Toshihiko Kinoshita, Alessandro Serretti, Masafumi Yoshimura, Ai Onohara, Shiho Sakai

Publikováno v: Neuropsychobiology. 73:35-42

Purpose: The aim of this study was to compare the effects of risperidone long-acting injection (RLAI) and paliperidone palmitate (PP) on non-acute-phase social functioning in patients with schizophrenia. Patients and Methods: In this 6-month pilot, o

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::681328c26dd86e40102fe5e63fc3d275
https://doi.org/10.1159/000442209

Zobrazit plný text záznamu

Cognitive function and risperidone long-acting injection vs. paliperidone palmitate in schizophrenia: A 6-month, open-label, randomized, pilot trial

Autor: Shiho Sakai, Keiichiro Nishida, Masaki Kato, Masafumi Yoshimura, Ai Onohara, Chiara Fabbri, Naotaka Sunada, Yoshiteru Takekita, Toshihiko Kinoshita, Alessandro Serretti, Yosuke Koshikawa

Publikováno v: BMC Psychiatry

Background Recently, long-acting injection (LAI) of second-generation antipsychotics has become a valuable strategy for the treatment of schizophrenia. However, few studies have compared the effects of different LAI antipsychotics on cognitive functi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44d5d2ccbf3c6185092a8b19c5b124d7
http://hdl.handle.net/11585/585592

Zobrazit plný text záznamu

Serotonin 7 Receptor Variants Are Not Associated with Response to Second-Generation Antipsychotics in Japanese Schizophrenia Patients

Autor: Masaki Kato, Toshihiko Kinoshita, Chiara Fabbri, Alessandro Serretti, Naotaka Sunada, Shinpei Nonen, Yosuke Koshikawa, Gaku Okugawa, Masataka Wakeno, Shiho Sakai, Yoshiteru Takekita

Background: Individual differences in serotonin 7 receptor (5-HT7R) may result in variable response to antipsychotics with 5-HT7R antagonism. This study investigated the relationship between single nucleotide polymorphisms (SNPs) in the 5-HT7R gene (

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10842f5bb96ffc1569e19417e9d0c60f
http://hdl.handle.net/11585/542909

Zobrazit plný text záznamu

HTR1A gene polymorphisms and 5-HT1A receptor partial agonist antipsychotics efficacy in Schizophrenia

Autor: Naotaka Sunada, Yosuke Koshikawa, Yoshiteru Takekita, Masaki Kato, Shinpei Nonen, Chiara Fabbri, Toshihiko Kinoshita, Gaku Okugawa, Masataka Wakeno, Shiho Sakai, Alessandro Serretti

Individual differences in serotonin 1A (5-HT1A) receptor may result in variable response to antipsychotics with 5-HT1A receptor partial agonism. We investigated the relationship between 5-HT1A receptor gene (HTR1A) single nucleotide polymorphisms (SN

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c755043b0e6d8dc01446b8e0512e8bb
http://hdl.handle.net/11585/542912

Zobrazit plný text záznamu

Antagonist and partial agonist at the dopamine D2 receptors in drug-naïve and non-drug-naïve schizophrenia: a randomized, controlled trial

Autor: Chiara Fabbri, Alessandro Serretti, Yoshiteru Takekita, Masataka Wakeno, Toshihiko Kinoshita, Shiho Sakai, Shinpei Nonen, Masaki Kato, Naotaka Sunada, Yosuke Koshikawa, Gaku Okugawa

Publikováno v: European archives of psychiatry and clinical neuroscience. 265(7)

Few data are available on the efficacy and safety of antipsychotics with different dopamine D2 receptor (D2-R)-binding properties in drug-naïve and non-drug-naïve schizophrenia. Thus, we aimed to assess whether antipsychotic medication history infl

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::415891255ec36fd175684abd456d4f95
https://pubmed.ncbi.nlm.nih.gov/26016467

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání